Cargando…
Identification of CD24 as a marker for tumorigenesis of melanoma
OBJECTIVE: Cutaneous melanoma (CM) is a common skin cancer. Surgery is still the primary treatment for CM, as melanoma is resistant to chemotherapy. In the recent years, it has been found that cancer stem-like cells (CSCs) are responsible for this drug resistance. CD24 is a widely used marker to iso...
Autores principales: | Tang, Ming-Rui, Guo, Jia-Yan, Wang, Di, Xu, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003289/ https://www.ncbi.nlm.nih.gov/pubmed/29928131 http://dx.doi.org/10.2147/OTT.S157043 |
Ejemplares similares
-
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017) -
Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018) -
Increasing CD44(+)/CD24(- )tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis
por: Wang, Kai-Hung, et al.
Publicado: (2010) -
Identification of Genes Potentially Associated with Melanoma Tumorigenesis Through Co-Expression Network Analysis
por: Xuan, Xiuyun, et al.
Publicado: (2021) -
Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients
por: Huang, Biao, et al.
Publicado: (2020)